ERBB2 and breast carcinoma: More recently, we showed that blocking autophagy by either FIP200 deletion or specifically block its canonical autophagy functions essentially alleviated the development of mammary tumors in the MMTV-Neu mouse model of breast cancer by perturbing the trafficking of oncogenic driver HER2 itself and promoting its release from tumor cells37.